(CAS No. 861205-83-6) Tesofencin Citrate

Product Details
Customization: Available
CAS No.: 861205-83-6
Formula: C23h31cl2no8
Still deciding? Get samples of US$ 1/kg
Order Sample
Shipping & Policy
Shipping Cost: Contact the supplier about freight and estimated delivery time.
Payment Methods:
visa mastercard discover JCB diners club american express T/T
PIX SPEI OXXO PSE OZOW
  Support payments in USD
Secure payments: Every payment you make on Made-in-China.com is protected by the platform.
Refund policy: Claim a refund if your order doesn't ship, is missing, or arrives with product issues.
Secured Trading Service
Gold Member Since 2022

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Registered Capital
2000000 RMB
Plant Area
101~500 square meters
  • (CAS No. 861205-83-6) Tesofencin Citrate
  • (CAS No. 861205-83-6) Tesofencin Citrate
  • (CAS No. 861205-83-6) Tesofencin Citrate
  • (CAS No. 861205-83-6) Tesofencin Citrate
  • (CAS No. 861205-83-6) Tesofencin Citrate
Find Similar Products

Basic Info.

Model NO.
861205-83-6
Acid-Base Property
Alkaline Surface Disposal Agent
Environmental Protection
Yes
Color
White
Transport Package
Barrel
Origin
China
HS Code
2918150000
Production Capacity
100000

Product Description

Product name Teso fensine citrate  Molecular formula C23H31Cl2NO8
CAS number 861205-83-6  Molecular weight 520.4
density N/A Boiling point N/A
MSDS N/A Fusing point N/A
(CAS No. 861205-83-6) Tesofencin Citrate(CAS No. 861205-83-6) Tesofencin Citrate(CAS No. 861205-83-6) Tesofencin Citrate(CAS No. 861205-83-6) Tesofencin Citrate(CAS No. 861205-83-6) Tesofencin Citrate(CAS No. 861205-83-6) Tesofencin Citrate
(CAS No. 861205-83-6) Tesofencin Citrate

Tesofencin citrate for use

 

Tesofe nsine Citrate is a serotonin reuptake inhibitor originally developed to treat Parkinson's disease and Alzheimer's disease. Tesofencin helps obese patients lose weight and lose weight from the right parts of their body and the right components (fat), according to a report by researchers at the 16th European Conference on Obesity.

Danish researchers studied the effects of Tesofencin treatment on body composition, including body weight, fat mass, waist circumference, and sagittal diameter. The study was a randomized, double-blind, placebo-controlled b clinical trial involving 203 obese men and women with a body mass index of 30-40 and no other medical conditions. After a 2-week dietary and physical activity induction period, they were assigned to drug therapy for 24 weeks, receiving doses of 0.25 mg, 0.5 mg, 1.0 mg of terexofencin daily or a corresponding placebo. The results show that Tesofencin is very effective against central obesity. Another study showed that low doses of tesofencin were safe and effective in treating obesity.


 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now